You may be a candidate for GLP-1 therapy if you have difficulty managing your weight despite consistent efforts with healthy eating and physical activity
28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
GPX1 is one of the most abundant members of the GPX family of enzymes
Supports intracellular and mitochondrial antioxidant processes
It is FDA-approved as Carnitor for carnitine deficiency, providing extensive human safety data
Each component has been independently examined in preclinical models for its potential involvement in distinct yet partly overlapping biological pathways